NPPA proposes making manufacturers solely responsible for essential medicine overpricing

The National Pharmaceutical Pricing Authority has proposed making manufacturers solely responsible for overpricing essential medicines, while removing prosecution risks for retailers, chemists and hospitals. The move is important as medicines may continue to be sold above revised prices, affecting affordability. The draft would remove action against downstream sellers for such violations.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.